Building Bridges Between Academia and Big Pharma
How does one of the world's leading pharmaceutical companies innovate and find new external opportunities? How can academics benefit from it?
Join us to hear firsthand from Johnson & Johnson how the company scouts, evaluates, and pursues external innovation, from collaborations to acquisitions. Whether you're a researcher wondering how your work catches industry attention or simply curious about how Big Pharma thinks, this is a session not to miss.
The afternoon will include a Q&A and plenty of time to connect with the speaker and fellow participants.
Join us to hear firsthand from Johnson & Johnson how the company scouts, evaluates, and pursues external innovation, from collaborations to acquisitions. Whether you're a researcher wondering how your work catches industry attention or simply curious about how Big Pharma thinks, this is a session not to miss.
The afternoon will include a Q&A and plenty of time to connect with the speaker and fellow participants.
Time
Wednesday, 29.04.26 - 02:00 PM
- 04:00 PM
Event format
Talk
Topic
Innovation, Pharma Industry, Research
Speaker
Ralf Angermund, Director Search & Evaluation Germany, External Scientific Innovation at Johnson & Johnson
Target groups
Students
Researchers
Languages
Englisch
Location
University Hospital Bonn, BMZ II
Reservation
required
Registration/Ticket
Organizer
Transfer Center enaCom, Nucleate Germany, Universitätsklinikum Bonn
Contact